MicroRNA (miRNA) Market to 2027 - Global Analysis and Forecasts By Product (Instruments, Consumables); Services (Sample Collection, miRNA cDNA Synthesis, miRNA Profiling and Purification, Next Generation Sequencing (NGS), Microarray, Real Time PCR (RT-PCR), Others); Application (Cardiovascular Diseases, Cancer, Neurological Diseases, Immunological Disorders, Infectious Diseases, Others); End User (Biotechnology and Pharmaceutical Companies, Academic and Government Research Institutes, Others), and Geography
Report Code: TIPRE00006698 No. of Pages: 150 Category: Biotechnology Status: Upcoming
MARKET INTRODUCTION
MicroRNAs (miRNA) recently discovered a class of non-coding RNAs, which play an imperative regulatory role in plants and animals by targeting specific mRNAs for translation repression or degradation. The miRNA is associated with the etiology disease, thus, has been studied for treatment. Moreover, numerous clinical and preclinical trials have been introduced for miRNA-based therapeutics.
MARKET DYNAMICS
The microRNA (miRNA) market is anticipated to grow in the forecast, owing to the increased adoption for use as a biomarker, high investments in miRNA and rising R&D initiatives for development of new diagnostic tests & therapeutics. However, increasing R&D activities and growing innovations in applications of miRNAs is likely to add novel opportunities in the forecast period for the market for forensic equipment and supplies.
MARKET SCOPE
The "Global MicroRNA (miRNA) Market Analysis to 2027" is a specialized and in-depth study of the medical industry with a special focus on the global market trend analysis. The report aims to provide an overview of microRNA (miRNA) market with detailed market segmentation by product, services, application, end user, and geography. The global microRNA (miRNA) market is expected to witness high growth during the forecast period. The report provides key information on the market status of the leading microRNA (miRNA) market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global microRNA (miRNA) market is segmented on the basis of product, application and end user. Based on product, the market is bifurcated into instruments and consumables. The services segment classified into sample collection, miRNA CDNA synthesis, miRNA profiling & purification, next generation sequencing (NGS), microarray, real time PCR (RT-PCR) and others. Based on the application, the market is categorized as cardiovascular diseases, cancer, neurological diseases, immunological disorders, infectious diseases and others. On the basis of end user, the microRNA (miRNA) market is segmented into biotechnology & pharmaceutical companies, academic & government research institutes and others.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global microRNA (miRNA) market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The microRNA (miRNA) market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting microRNA (miRNA) market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the microRNA (miRNA) market in these regions.
The report covers key developments in the microRNA (miRNA) market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from microRNA (miRNA) market are anticipated to have lucrative growth opportunities in the future with the rising demand for microRNA (miRNA) market in the global market. Below mentioned is the list of few companies engaged in the microRNA (miRNA) market.
The report also includes the profiles of key microRNA (miRNA) market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
MicroRNAs (miRNA) recently discovered a class of non-coding RNAs, which play an imperative regulatory role in plants and animals by targeting specific mRNAs for translation repression or degradation. The miRNA is associated with the etiology disease, thus, has been studied for treatment. Moreover, numerous clinical and preclinical trials have been introduced for miRNA-based therapeutics.
MARKET DYNAMICS
The microRNA (miRNA) market is anticipated to grow in the forecast, owing to the increased adoption for use as a biomarker, high investments in miRNA and rising R&D initiatives for development of new diagnostic tests & therapeutics. However, increasing R&D activities and growing innovations in applications of miRNAs is likely to add novel opportunities in the forecast period for the market for forensic equipment and supplies.
MARKET SCOPE
The "Global MicroRNA (miRNA) Market Analysis to 2027" is a specialized and in-depth study of the medical industry with a special focus on the global market trend analysis. The report aims to provide an overview of microRNA (miRNA) market with detailed market segmentation by product, services, application, end user, and geography. The global microRNA (miRNA) market is expected to witness high growth during the forecast period. The report provides key information on the market status of the leading microRNA (miRNA) market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global microRNA (miRNA) market is segmented on the basis of product, application and end user. Based on product, the market is bifurcated into instruments and consumables. The services segment classified into sample collection, miRNA CDNA synthesis, miRNA profiling & purification, next generation sequencing (NGS), microarray, real time PCR (RT-PCR) and others. Based on the application, the market is categorized as cardiovascular diseases, cancer, neurological diseases, immunological disorders, infectious diseases and others. On the basis of end user, the microRNA (miRNA) market is segmented into biotechnology & pharmaceutical companies, academic & government research institutes and others.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global microRNA (miRNA) market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The microRNA (miRNA) market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting microRNA (miRNA) market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the microRNA (miRNA) market in these regions.
The report covers key developments in the microRNA (miRNA) market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from microRNA (miRNA) market are anticipated to have lucrative growth opportunities in the future with the rising demand for microRNA (miRNA) market in the global market. Below mentioned is the list of few companies engaged in the microRNA (miRNA) market.
The report also includes the profiles of key microRNA (miRNA) market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Merck KGaA
- Thermo Fisher Scientific Inc.
- QIAGEN
- GeneCopoeia, Inc.
- BioGenex
- NanoString Technologies, Inc.
- Synlogic
- Dharmacon
- SeqMatic LLC.
- Quantabio
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 MicroRNA (miRNA) Market - By Product
1.3.2 MicroRNA (miRNA) Market - By Services
1.3.3 MicroRNA (miRNA) Market - By Application
1.3.4 MicroRNA (miRNA) Market - By End User
1.3.5 MicroRNA (miRNA) Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. MICRORNA (MIRNA) MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. MICRORNA (MIRNA) MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. MICRORNA (MIRNA) MARKET - GLOBAL MARKET ANALYSIS
6.1. MICRORNA (MIRNA) - GLOBAL MARKET OVERVIEW
6.2. MICRORNA (MIRNA) - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. MICRORNA (MIRNA) MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. INSTRUMENTS
7.3.1. Overview
7.3.2. Instruments Market Forecast and Analysis
7.4. CONSUMABLES
7.4.1. Overview
7.4.2. Consumables Market Forecast and Analysis
7.4.3. Isolation and Purification Market
7.4.3.1. Overview
7.4.3.2. Isolation and Purification Market Forecast and Analysis
7.4.4. Quantification and Detection Market
7.4.4.1. Overview
7.4.4.2. Quantification and Detection Market Forecast and Analysis
7.4.5. Functional Analysis Market
7.4.5.1. Overview
7.4.5.2. Functional Analysis Market Forecast and Analysis
7.4.6. Others Market
7.4.6.1. Overview
7.4.6.2. Others Market Forecast and Analysis
8. MICRORNA (MIRNA) MARKET - REVENUE AND FORECASTS TO 2027 - SERVICES
8.1. OVERVIEW
8.2. SERVICES MARKET FORECASTS AND ANALYSIS
8.3. SAMPLE COLLECTION
8.3.1. Overview
8.3.2. Sample Collection Market Forecast and Analysis
8.3.3. Whole blood Market
8.3.3.1. Overview
8.3.3.2. Whole blood Market Forecast and Analysis
8.3.4. Serum Market
8.3.4.1. Overview
8.3.4.2. Serum Market Forecast and Analysis
8.3.5. Plasma Market
8.3.5.1. Overview
8.3.5.2. Plasma Market Forecast and Analysis
8.4. MIRNA CDNA SYNTHESIS
8.4.1. Overview
8.4.2. miRNA cDNA Synthesis Market Forecast and Analysis
8.5. MIRNA PROFILING AND PURIFICATION
8.5.1. Overview
8.5.2. miRNA Profiling and Purification Market Forecast and Analysis
8.6. NEXT GENERATION SEQUENCING (NGS)
8.6.1. Overview
8.6.2. Next Generation Sequencing (NGS) Market Forecast and Analysis
8.7. MICROARRAY
8.7.1. Overview
8.7.2. Microarray Market Forecast and Analysis
8.8. REAL TIME PCR (RT-PCR)
8.8.1. Overview
8.8.2. Real Time PCR (RT-PCR) Market Forecast and Analysis
8.9. OTHERS
8.9.1. Overview
8.9.2. Others Market Forecast and Analysis
9. MICRORNA (MIRNA) MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. CARDIOVASCULAR DISEASES
9.3.1. Overview
9.3.2. Cardiovascular Diseases Market Forecast and Analysis
9.4. CANCER
9.4.1. Overview
9.4.2. Cancer Market Forecast and Analysis
9.5. NEUROLOGICAL DISEASES
9.5.1. Overview
9.5.2. Neurological Diseases Market Forecast and Analysis
9.6. IMMUNOLOGICAL DISORDERS
9.6.1. Overview
9.6.2. Immunological Disorders Market Forecast and Analysis
9.7. INFECTIOUS DISEASES
9.7.1. Overview
9.7.2. Infectious Diseases Market Forecast and Analysis
9.8. OTHERS
9.8.1. Overview
9.8.2. Others Market Forecast and Analysis
10. MICRORNA (MIRNA) MARKET - REVENUE AND FORECASTS TO 2027 - END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES
10.3.1. Overview
10.3.2. Biotechnology and Pharmaceutical Companies Market Forecast and Analysis
10.4. ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES
10.4.1. Overview
10.4.2. Academic and Government Research Institutes Market Forecast and Analysis
10.5. OTHERS
10.5.1. Overview
10.5.2. Others Market Forecast and Analysis
11. MICRORNA (MIRNA) MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America MicroRNA (miRNA) Market Overview
11.1.2 North America MicroRNA (miRNA) Market Forecasts and Analysis
11.1.3 North America MicroRNA (miRNA) Market Forecasts and Analysis - By Product
11.1.4 North America MicroRNA (miRNA) Market Forecasts and Analysis - By Services
11.1.5 North America MicroRNA (miRNA) Market Forecasts and Analysis - By Application
11.1.6 North America MicroRNA (miRNA) Market Forecasts and Analysis - By End User
11.1.7 North America MicroRNA (miRNA) Market Forecasts and Analysis - By Countries
11.1.7.1 United States MicroRNA (miRNA) Market
11.1.7.1.1 United States MicroRNA (miRNA) Market by Product
11.1.7.1.2 United States MicroRNA (miRNA) Market by Services
11.1.7.1.3 United States MicroRNA (miRNA) Market by Application
11.1.7.1.4 United States MicroRNA (miRNA) Market by End User
11.1.7.2 Canada MicroRNA (miRNA) Market
11.1.7.2.1 Canada MicroRNA (miRNA) Market by Product
11.1.7.2.2 Canada MicroRNA (miRNA) Market by Services
11.1.7.2.3 Canada MicroRNA (miRNA) Market by Application
11.1.7.2.4 Canada MicroRNA (miRNA) Market by End User
11.1.7.3 Mexico MicroRNA (miRNA) Market
11.1.7.3.1 Mexico MicroRNA (miRNA) Market by Product
11.1.7.3.2 Mexico MicroRNA (miRNA) Market by Services
11.1.7.3.3 Mexico MicroRNA (miRNA) Market by Application
11.1.7.3.4 Mexico MicroRNA (miRNA) Market by End User
11.2. EUROPE
11.2.1 Europe MicroRNA (miRNA) Market Overview
11.2.2 Europe MicroRNA (miRNA) Market Forecasts and Analysis
11.2.3 Europe MicroRNA (miRNA) Market Forecasts and Analysis - By Product
11.2.4 Europe MicroRNA (miRNA) Market Forecasts and Analysis - By Services
11.2.5 Europe MicroRNA (miRNA) Market Forecasts and Analysis - By Application
11.2.6 Europe MicroRNA (miRNA) Market Forecasts and Analysis - By End User
11.2.7 Europe MicroRNA (miRNA) Market Forecasts and Analysis - By Countries
11.2.7.1 Germany MicroRNA (miRNA) Market
11.2.7.1.1 Germany MicroRNA (miRNA) Market by Product
11.2.7.1.2 Germany MicroRNA (miRNA) Market by Services
11.2.7.1.3 Germany MicroRNA (miRNA) Market by Application
11.2.7.1.4 Germany MicroRNA (miRNA) Market by End User
11.2.7.2 France MicroRNA (miRNA) Market
11.2.7.2.1 France MicroRNA (miRNA) Market by Product
11.2.7.2.2 France MicroRNA (miRNA) Market by Services
11.2.7.2.3 France MicroRNA (miRNA) Market by Application
11.2.7.2.4 France MicroRNA (miRNA) Market by End User
11.2.7.3 Italy MicroRNA (miRNA) Market
11.2.7.3.1 Italy MicroRNA (miRNA) Market by Product
11.2.7.3.2 Italy MicroRNA (miRNA) Market by Services
11.2.7.3.3 Italy MicroRNA (miRNA) Market by Application
11.2.7.3.4 Italy MicroRNA (miRNA) Market by End User
11.2.7.4 Spain MicroRNA (miRNA) Market
11.2.7.4.1 Spain MicroRNA (miRNA) Market by Product
11.2.7.4.2 Spain MicroRNA (miRNA) Market by Services
11.2.7.4.3 Spain MicroRNA (miRNA) Market by Application
11.2.7.4.4 Spain MicroRNA (miRNA) Market by End User
11.2.7.5 United Kingdom MicroRNA (miRNA) Market
11.2.7.5.1 United Kingdom MicroRNA (miRNA) Market by Product
11.2.7.5.2 United Kingdom MicroRNA (miRNA) Market by Services
11.2.7.5.3 United Kingdom MicroRNA (miRNA) Market by Application
11.2.7.5.4 United Kingdom MicroRNA (miRNA) Market by End User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific MicroRNA (miRNA) Market Overview
11.3.2 Asia-Pacific MicroRNA (miRNA) Market Forecasts and Analysis
11.3.3 Asia-Pacific MicroRNA (miRNA) Market Forecasts and Analysis - By Product
11.3.4 Asia-Pacific MicroRNA (miRNA) Market Forecasts and Analysis - By Services
11.3.5 Asia-Pacific MicroRNA (miRNA) Market Forecasts and Analysis - By Application
11.3.6 Asia-Pacific MicroRNA (miRNA) Market Forecasts and Analysis - By End User
11.3.7 Asia-Pacific MicroRNA (miRNA) Market Forecasts and Analysis - By Countries
11.3.7.1 Australia MicroRNA (miRNA) Market
11.3.7.1.1 Australia MicroRNA (miRNA) Market by Product
11.3.7.1.2 Australia MicroRNA (miRNA) Market by Services
11.3.7.1.3 Australia MicroRNA (miRNA) Market by Application
11.3.7.1.4 Australia MicroRNA (miRNA) Market by End User
11.3.7.2 China MicroRNA (miRNA) Market
11.3.7.2.1 China MicroRNA (miRNA) Market by Product
11.3.7.2.2 China MicroRNA (miRNA) Market by Services
11.3.7.2.3 China MicroRNA (miRNA) Market by Application
11.3.7.2.4 China MicroRNA (miRNA) Market by End User
11.3.7.3 India MicroRNA (miRNA) Market
11.3.7.3.1 India MicroRNA (miRNA) Market by Product
11.3.7.3.2 India MicroRNA (miRNA) Market by Services
11.3.7.3.3 India MicroRNA (miRNA) Market by Application
11.3.7.3.4 India MicroRNA (miRNA) Market by End User
11.3.7.4 Japan MicroRNA (miRNA) Market
11.3.7.4.1 Japan MicroRNA (miRNA) Market by Product
11.3.7.4.2 Japan MicroRNA (miRNA) Market by Services
11.3.7.4.3 Japan MicroRNA (miRNA) Market by Application
11.3.7.4.4 Japan MicroRNA (miRNA) Market by End User
11.3.7.5 South Korea MicroRNA (miRNA) Market
11.3.7.5.1 South Korea MicroRNA (miRNA) Market by Product
11.3.7.5.2 South Korea MicroRNA (miRNA) Market by Services
11.3.7.5.3 South Korea MicroRNA (miRNA) Market by Application
11.3.7.5.4 South Korea MicroRNA (miRNA) Market by End User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa MicroRNA (miRNA) Market Overview
11.4.2 Middle East and Africa MicroRNA (miRNA) Market Forecasts and Analysis
11.4.3 Middle East and Africa MicroRNA (miRNA) Market Forecasts and Analysis - By Product
11.4.4 Middle East and Africa MicroRNA (miRNA) Market Forecasts and Analysis - By Services
11.4.5 Middle East and Africa MicroRNA (miRNA) Market Forecasts and Analysis - By Application
11.4.6 Middle East and Africa MicroRNA (miRNA) Market Forecasts and Analysis - By End User
11.4.7 Middle East and Africa MicroRNA (miRNA) Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa MicroRNA (miRNA) Market
11.4.7.1.1 South Africa MicroRNA (miRNA) Market by Product
11.4.7.1.2 South Africa MicroRNA (miRNA) Market by Services
11.4.7.1.3 South Africa MicroRNA (miRNA) Market by Application
11.4.7.1.4 South Africa MicroRNA (miRNA) Market by End User
11.4.7.2 Saudi Arabia MicroRNA (miRNA) Market
11.4.7.2.1 Saudi Arabia MicroRNA (miRNA) Market by Product
11.4.7.2.2 Saudi Arabia MicroRNA (miRNA) Market by Services
11.4.7.2.3 Saudi Arabia MicroRNA (miRNA) Market by Application
11.4.7.2.4 Saudi Arabia MicroRNA (miRNA) Market by End User
11.4.7.3 U.A.E MicroRNA (miRNA) Market
11.4.7.3.1 U.A.E MicroRNA (miRNA) Market by Product
11.4.7.3.2 U.A.E MicroRNA (miRNA) Market by Services
11.4.7.3.3 U.A.E MicroRNA (miRNA) Market by Application
11.4.7.3.4 U.A.E MicroRNA (miRNA) Market by End User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America MicroRNA (miRNA) Market Overview
11.5.2 South and Central America MicroRNA (miRNA) Market Forecasts and Analysis
11.5.3 South and Central America MicroRNA (miRNA) Market Forecasts and Analysis - By Product
11.5.4 South and Central America MicroRNA (miRNA) Market Forecasts and Analysis - By Services
11.5.5 South and Central America MicroRNA (miRNA) Market Forecasts and Analysis - By Application
11.5.6 South and Central America MicroRNA (miRNA) Market Forecasts and Analysis - By End User
11.5.7 South and Central America MicroRNA (miRNA) Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil MicroRNA (miRNA) Market
11.5.7.1.1 Brazil MicroRNA (miRNA) Market by Product
11.5.7.1.2 Brazil MicroRNA (miRNA) Market by Services
11.5.7.1.3 Brazil MicroRNA (miRNA) Market by Application
11.5.7.1.4 Brazil MicroRNA (miRNA) Market by End User
11.5.7.2 Argentina MicroRNA (miRNA) Market
11.5.7.2.1 Argentina MicroRNA (miRNA) Market by Product
11.5.7.2.2 Argentina MicroRNA (miRNA) Market by Services
11.5.7.2.3 Argentina MicroRNA (miRNA) Market by Application
11.5.7.2.4 Argentina MicroRNA (miRNA) Market by End User
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. MICRORNA (MIRNA) MARKET, KEY COMPANY PROFILES
13.1. MERCK KGAA
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. THERMO FISHER SCIENTIFIC INC.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. QIAGEN
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. GENECOPOEIA, INC.
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. BIOGENEX
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. NANOSTRING TECHNOLOGIES, INC.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. SYNLOGIC
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. DHARMACON
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. SEQMATIC LLC.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. QUANTABIO
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 MicroRNA (miRNA) Market - By Product
1.3.2 MicroRNA (miRNA) Market - By Services
1.3.3 MicroRNA (miRNA) Market - By Application
1.3.4 MicroRNA (miRNA) Market - By End User
1.3.5 MicroRNA (miRNA) Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. MICRORNA (MIRNA) MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. MICRORNA (MIRNA) MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. MICRORNA (MIRNA) MARKET - GLOBAL MARKET ANALYSIS
6.1. MICRORNA (MIRNA) - GLOBAL MARKET OVERVIEW
6.2. MICRORNA (MIRNA) - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. MICRORNA (MIRNA) MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. INSTRUMENTS
7.3.1. Overview
7.3.2. Instruments Market Forecast and Analysis
7.4. CONSUMABLES
7.4.1. Overview
7.4.2. Consumables Market Forecast and Analysis
7.4.3. Isolation and Purification Market
7.4.3.1. Overview
7.4.3.2. Isolation and Purification Market Forecast and Analysis
7.4.4. Quantification and Detection Market
7.4.4.1. Overview
7.4.4.2. Quantification and Detection Market Forecast and Analysis
7.4.5. Functional Analysis Market
7.4.5.1. Overview
7.4.5.2. Functional Analysis Market Forecast and Analysis
7.4.6. Others Market
7.4.6.1. Overview
7.4.6.2. Others Market Forecast and Analysis
8. MICRORNA (MIRNA) MARKET - REVENUE AND FORECASTS TO 2027 - SERVICES
8.1. OVERVIEW
8.2. SERVICES MARKET FORECASTS AND ANALYSIS
8.3. SAMPLE COLLECTION
8.3.1. Overview
8.3.2. Sample Collection Market Forecast and Analysis
8.3.3. Whole blood Market
8.3.3.1. Overview
8.3.3.2. Whole blood Market Forecast and Analysis
8.3.4. Serum Market
8.3.4.1. Overview
8.3.4.2. Serum Market Forecast and Analysis
8.3.5. Plasma Market
8.3.5.1. Overview
8.3.5.2. Plasma Market Forecast and Analysis
8.4. MIRNA CDNA SYNTHESIS
8.4.1. Overview
8.4.2. miRNA cDNA Synthesis Market Forecast and Analysis
8.5. MIRNA PROFILING AND PURIFICATION
8.5.1. Overview
8.5.2. miRNA Profiling and Purification Market Forecast and Analysis
8.6. NEXT GENERATION SEQUENCING (NGS)
8.6.1. Overview
8.6.2. Next Generation Sequencing (NGS) Market Forecast and Analysis
8.7. MICROARRAY
8.7.1. Overview
8.7.2. Microarray Market Forecast and Analysis
8.8. REAL TIME PCR (RT-PCR)
8.8.1. Overview
8.8.2. Real Time PCR (RT-PCR) Market Forecast and Analysis
8.9. OTHERS
8.9.1. Overview
8.9.2. Others Market Forecast and Analysis
9. MICRORNA (MIRNA) MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. CARDIOVASCULAR DISEASES
9.3.1. Overview
9.3.2. Cardiovascular Diseases Market Forecast and Analysis
9.4. CANCER
9.4.1. Overview
9.4.2. Cancer Market Forecast and Analysis
9.5. NEUROLOGICAL DISEASES
9.5.1. Overview
9.5.2. Neurological Diseases Market Forecast and Analysis
9.6. IMMUNOLOGICAL DISORDERS
9.6.1. Overview
9.6.2. Immunological Disorders Market Forecast and Analysis
9.7. INFECTIOUS DISEASES
9.7.1. Overview
9.7.2. Infectious Diseases Market Forecast and Analysis
9.8. OTHERS
9.8.1. Overview
9.8.2. Others Market Forecast and Analysis
10. MICRORNA (MIRNA) MARKET - REVENUE AND FORECASTS TO 2027 - END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES
10.3.1. Overview
10.3.2. Biotechnology and Pharmaceutical Companies Market Forecast and Analysis
10.4. ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES
10.4.1. Overview
10.4.2. Academic and Government Research Institutes Market Forecast and Analysis
10.5. OTHERS
10.5.1. Overview
10.5.2. Others Market Forecast and Analysis
11. MICRORNA (MIRNA) MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America MicroRNA (miRNA) Market Overview
11.1.2 North America MicroRNA (miRNA) Market Forecasts and Analysis
11.1.3 North America MicroRNA (miRNA) Market Forecasts and Analysis - By Product
11.1.4 North America MicroRNA (miRNA) Market Forecasts and Analysis - By Services
11.1.5 North America MicroRNA (miRNA) Market Forecasts and Analysis - By Application
11.1.6 North America MicroRNA (miRNA) Market Forecasts and Analysis - By End User
11.1.7 North America MicroRNA (miRNA) Market Forecasts and Analysis - By Countries
11.1.7.1 United States MicroRNA (miRNA) Market
11.1.7.1.1 United States MicroRNA (miRNA) Market by Product
11.1.7.1.2 United States MicroRNA (miRNA) Market by Services
11.1.7.1.3 United States MicroRNA (miRNA) Market by Application
11.1.7.1.4 United States MicroRNA (miRNA) Market by End User
11.1.7.2 Canada MicroRNA (miRNA) Market
11.1.7.2.1 Canada MicroRNA (miRNA) Market by Product
11.1.7.2.2 Canada MicroRNA (miRNA) Market by Services
11.1.7.2.3 Canada MicroRNA (miRNA) Market by Application
11.1.7.2.4 Canada MicroRNA (miRNA) Market by End User
11.1.7.3 Mexico MicroRNA (miRNA) Market
11.1.7.3.1 Mexico MicroRNA (miRNA) Market by Product
11.1.7.3.2 Mexico MicroRNA (miRNA) Market by Services
11.1.7.3.3 Mexico MicroRNA (miRNA) Market by Application
11.1.7.3.4 Mexico MicroRNA (miRNA) Market by End User
11.2. EUROPE
11.2.1 Europe MicroRNA (miRNA) Market Overview
11.2.2 Europe MicroRNA (miRNA) Market Forecasts and Analysis
11.2.3 Europe MicroRNA (miRNA) Market Forecasts and Analysis - By Product
11.2.4 Europe MicroRNA (miRNA) Market Forecasts and Analysis - By Services
11.2.5 Europe MicroRNA (miRNA) Market Forecasts and Analysis - By Application
11.2.6 Europe MicroRNA (miRNA) Market Forecasts and Analysis - By End User
11.2.7 Europe MicroRNA (miRNA) Market Forecasts and Analysis - By Countries
11.2.7.1 Germany MicroRNA (miRNA) Market
11.2.7.1.1 Germany MicroRNA (miRNA) Market by Product
11.2.7.1.2 Germany MicroRNA (miRNA) Market by Services
11.2.7.1.3 Germany MicroRNA (miRNA) Market by Application
11.2.7.1.4 Germany MicroRNA (miRNA) Market by End User
11.2.7.2 France MicroRNA (miRNA) Market
11.2.7.2.1 France MicroRNA (miRNA) Market by Product
11.2.7.2.2 France MicroRNA (miRNA) Market by Services
11.2.7.2.3 France MicroRNA (miRNA) Market by Application
11.2.7.2.4 France MicroRNA (miRNA) Market by End User
11.2.7.3 Italy MicroRNA (miRNA) Market
11.2.7.3.1 Italy MicroRNA (miRNA) Market by Product
11.2.7.3.2 Italy MicroRNA (miRNA) Market by Services
11.2.7.3.3 Italy MicroRNA (miRNA) Market by Application
11.2.7.3.4 Italy MicroRNA (miRNA) Market by End User
11.2.7.4 Spain MicroRNA (miRNA) Market
11.2.7.4.1 Spain MicroRNA (miRNA) Market by Product
11.2.7.4.2 Spain MicroRNA (miRNA) Market by Services
11.2.7.4.3 Spain MicroRNA (miRNA) Market by Application
11.2.7.4.4 Spain MicroRNA (miRNA) Market by End User
11.2.7.5 United Kingdom MicroRNA (miRNA) Market
11.2.7.5.1 United Kingdom MicroRNA (miRNA) Market by Product
11.2.7.5.2 United Kingdom MicroRNA (miRNA) Market by Services
11.2.7.5.3 United Kingdom MicroRNA (miRNA) Market by Application
11.2.7.5.4 United Kingdom MicroRNA (miRNA) Market by End User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific MicroRNA (miRNA) Market Overview
11.3.2 Asia-Pacific MicroRNA (miRNA) Market Forecasts and Analysis
11.3.3 Asia-Pacific MicroRNA (miRNA) Market Forecasts and Analysis - By Product
11.3.4 Asia-Pacific MicroRNA (miRNA) Market Forecasts and Analysis - By Services
11.3.5 Asia-Pacific MicroRNA (miRNA) Market Forecasts and Analysis - By Application
11.3.6 Asia-Pacific MicroRNA (miRNA) Market Forecasts and Analysis - By End User
11.3.7 Asia-Pacific MicroRNA (miRNA) Market Forecasts and Analysis - By Countries
11.3.7.1 Australia MicroRNA (miRNA) Market
11.3.7.1.1 Australia MicroRNA (miRNA) Market by Product
11.3.7.1.2 Australia MicroRNA (miRNA) Market by Services
11.3.7.1.3 Australia MicroRNA (miRNA) Market by Application
11.3.7.1.4 Australia MicroRNA (miRNA) Market by End User
11.3.7.2 China MicroRNA (miRNA) Market
11.3.7.2.1 China MicroRNA (miRNA) Market by Product
11.3.7.2.2 China MicroRNA (miRNA) Market by Services
11.3.7.2.3 China MicroRNA (miRNA) Market by Application
11.3.7.2.4 China MicroRNA (miRNA) Market by End User
11.3.7.3 India MicroRNA (miRNA) Market
11.3.7.3.1 India MicroRNA (miRNA) Market by Product
11.3.7.3.2 India MicroRNA (miRNA) Market by Services
11.3.7.3.3 India MicroRNA (miRNA) Market by Application
11.3.7.3.4 India MicroRNA (miRNA) Market by End User
11.3.7.4 Japan MicroRNA (miRNA) Market
11.3.7.4.1 Japan MicroRNA (miRNA) Market by Product
11.3.7.4.2 Japan MicroRNA (miRNA) Market by Services
11.3.7.4.3 Japan MicroRNA (miRNA) Market by Application
11.3.7.4.4 Japan MicroRNA (miRNA) Market by End User
11.3.7.5 South Korea MicroRNA (miRNA) Market
11.3.7.5.1 South Korea MicroRNA (miRNA) Market by Product
11.3.7.5.2 South Korea MicroRNA (miRNA) Market by Services
11.3.7.5.3 South Korea MicroRNA (miRNA) Market by Application
11.3.7.5.4 South Korea MicroRNA (miRNA) Market by End User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa MicroRNA (miRNA) Market Overview
11.4.2 Middle East and Africa MicroRNA (miRNA) Market Forecasts and Analysis
11.4.3 Middle East and Africa MicroRNA (miRNA) Market Forecasts and Analysis - By Product
11.4.4 Middle East and Africa MicroRNA (miRNA) Market Forecasts and Analysis - By Services
11.4.5 Middle East and Africa MicroRNA (miRNA) Market Forecasts and Analysis - By Application
11.4.6 Middle East and Africa MicroRNA (miRNA) Market Forecasts and Analysis - By End User
11.4.7 Middle East and Africa MicroRNA (miRNA) Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa MicroRNA (miRNA) Market
11.4.7.1.1 South Africa MicroRNA (miRNA) Market by Product
11.4.7.1.2 South Africa MicroRNA (miRNA) Market by Services
11.4.7.1.3 South Africa MicroRNA (miRNA) Market by Application
11.4.7.1.4 South Africa MicroRNA (miRNA) Market by End User
11.4.7.2 Saudi Arabia MicroRNA (miRNA) Market
11.4.7.2.1 Saudi Arabia MicroRNA (miRNA) Market by Product
11.4.7.2.2 Saudi Arabia MicroRNA (miRNA) Market by Services
11.4.7.2.3 Saudi Arabia MicroRNA (miRNA) Market by Application
11.4.7.2.4 Saudi Arabia MicroRNA (miRNA) Market by End User
11.4.7.3 U.A.E MicroRNA (miRNA) Market
11.4.7.3.1 U.A.E MicroRNA (miRNA) Market by Product
11.4.7.3.2 U.A.E MicroRNA (miRNA) Market by Services
11.4.7.3.3 U.A.E MicroRNA (miRNA) Market by Application
11.4.7.3.4 U.A.E MicroRNA (miRNA) Market by End User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America MicroRNA (miRNA) Market Overview
11.5.2 South and Central America MicroRNA (miRNA) Market Forecasts and Analysis
11.5.3 South and Central America MicroRNA (miRNA) Market Forecasts and Analysis - By Product
11.5.4 South and Central America MicroRNA (miRNA) Market Forecasts and Analysis - By Services
11.5.5 South and Central America MicroRNA (miRNA) Market Forecasts and Analysis - By Application
11.5.6 South and Central America MicroRNA (miRNA) Market Forecasts and Analysis - By End User
11.5.7 South and Central America MicroRNA (miRNA) Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil MicroRNA (miRNA) Market
11.5.7.1.1 Brazil MicroRNA (miRNA) Market by Product
11.5.7.1.2 Brazil MicroRNA (miRNA) Market by Services
11.5.7.1.3 Brazil MicroRNA (miRNA) Market by Application
11.5.7.1.4 Brazil MicroRNA (miRNA) Market by End User
11.5.7.2 Argentina MicroRNA (miRNA) Market
11.5.7.2.1 Argentina MicroRNA (miRNA) Market by Product
11.5.7.2.2 Argentina MicroRNA (miRNA) Market by Services
11.5.7.2.3 Argentina MicroRNA (miRNA) Market by Application
11.5.7.2.4 Argentina MicroRNA (miRNA) Market by End User
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. MICRORNA (MIRNA) MARKET, KEY COMPANY PROFILES
13.1. MERCK KGAA
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. THERMO FISHER SCIENTIFIC INC.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. QIAGEN
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. GENECOPOEIA, INC.
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. BIOGENEX
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. NANOSTRING TECHNOLOGIES, INC.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. SYNLOGIC
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. DHARMACON
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. SEQMATIC LLC.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. QUANTABIO
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies
1. Merck KGaA
2. Thermo Fisher Scientific Inc.
3. QIAGEN
4. GeneCopoeia, Inc.
5. BioGenex
6. NanoString Technologies, Inc.
7. Synlogic
8. Dharmacon
9. SeqMatic LLC.
10. Quantabio